RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 107 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,495 | +1249.4% | 152,443 | +872.2% | 0.03% | +1550.0% |
| Q2 2023 | $259 | -72.9% | 15,681 | -70.8% | 0.00% | -75.0% |
| Q1 2023 | $957 | -99.4% | 53,658 | +246.7% | 0.01% | +300.0% |
| Q4 2021 | $154,000 | +1.3% | 15,475 | +33.4% | 0.00% | 0.0% |
| Q3 2021 | $152,000 | -48.1% | 11,601 | -22.4% | 0.00% | -33.3% |
| Q2 2021 | $293,000 | -2.7% | 14,944 | +10.8% | 0.00% | -62.5% |
| Q2 2020 | $301,000 | -43.9% | 13,483 | -31.2% | 0.01% | -80.0% |
| Q1 2019 | $537,000 | – | 19,596 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |